Validation of the octamouse for simultaneous 18F-fallypride small-animal PET recordings from 8 mice

Journal of Nuclear Medicine

Volumn 51, Issue 10, 2010, Pages 1576-1583

  Rominger, Axel ^a   Mille, Erik ^a   Zhang, Shanshan ^b   Böning, Guido ^a   Förster, Stefan ^a   Nowak, Sebastian ^a   Gildehaus, Franz Josef ^a   Wängler, Björn ^a   Bartenstein, Peter ^a   Cumming, Paul ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Dopamine D2 3 receptor; Fallypride; Mouse brain; Octamouse holder; Small animal PET

Indexed keywords

ACRYLIC ACID; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; FALLYPRIDE F 18; FLUORINE 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CORPUS STRIATUM; DEVICE; FEMALE; MOUSE; NEUROIMAGING; NONHUMAN; OCTAMOUSE; PHANTOM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION SCATTERING; RADIOACTIVITY; VALIDATION STUDY;

ANIMALS; BENZAMIDES; BRAIN; DRUG EVALUATION, PRECLINICAL; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FEMALE; MICE; MICE, INBRED BALB C; POSITRON-EMISSION TOMOGRAPHY; PYRROLIDINES; RADIOPHARMACEUTICALS;

EID: 79851482772     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.078451     Document Type: Article

References (29)

1. 2/3 receptors in striatum of living mouse. Synapse. 2010;64:654-657.
2. 2/3 receptors in brain of living mouse. Synapse. 2010;64:313-322.
3. 18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar. Neuroimage. 2010;49:1406-1415.
4. Cheng TE, Yoder KK, Normandin MD, et al. A rat head holder for simultaneous scanning of two rats in small animal PET scanners: design, construction, feasibility testing and kinetic validation. J Neurosci Methods. 2009;176:24-33.
5. Skinbjerg M. Dopamine D2 Receptor Pharmacology: In Vitro Analyses and In Vivo PET Imaging [Ph.D. dissertation]. Stockholm, Sweden: Karolinska Institute; 2009.
6. 18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer. Nucl Med Biol. 1995;22:283-296.
7. Watson CC. New, faster, image-based scatter correction for 3D PET. IEEE Trans Nucl Sci. 2000;47:1587-1594.
8. Dorr A, Sled JG, Kabani N. Three-dimensional cerebral vasculature of the CBA mouse brain: a magnetic resonance imaging and micro computed tomography study. Neuroimage. 2007;35:1409-1423. (Pubitemid 46561347)
9. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16:834-840. (Pubitemid 26292051)
10. 2/3 receptors of caudate nucleus is lost with age. Neuroimage. 2007;34:870-878.
11. Rubins DJ, Meadors AK, Yee S, Melega WP, Cherry SR. Evaluation of a stereotactic frame for repositioning of the rat brain in serial positron emission tomography imaging studies. J Neurosci Methods. 2001;107:63-70. (Pubitemid 32492298)
12. Suckow C, Kuntner C, Chow P, Silverman R, Chatziioannou A, Stout D. Multimodality rodent imaging chambers for use under barrier conditions with gas anesthesia. Mol Imaging Biol. 2009;11:100-106.
13. Rice SA, Sbordone L, Mazze RI. Metabolism by rat hepatic microsomes of fluorinated ether anesthetics following isoniazid administration. Anesthesiology. 1980;53:489-493. (Pubitemid 11205199)
14. Burke TR Jr., Martin JL, George JW, Pohl LR. Investigation of the mechanism of defluorination of enflurane in rat liver microsomes with specifically deuterated derivatives. Biochem Pharmacol. 1980;29:1623-1626. (Pubitemid 10101926)
15. Kemp BJ, Hruska CB, McFarland AR, Lenox MW, Lowe VJ. NEMA NU 2-2007 performance measurements of the Siemens Inveon preclinical small animal PET system. Phys Med Biol. 2009;54:2359-2376.
16. 11C]raclopride to dopamine D2,3 receptors in pig brain. Neuroimage. 2003;19:1127-1136.
17. 2 receptors in mice using quad-HIDAC PET. J Nucl Med. 2004;45:464-470.
18. Skinbjerg M, Liow JS, Seneca N, et al. D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse model. Neuroimage. 2010;50:1402-1407.
19. Dalley JW, Fryer TD, Brichard L, et al. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science. 2007;315:1267-1270. (Pubitemid 46364262)
20. Yakushev IY, Dupont E, Buchholz HG, et al. In vivo imaging of dopamine receptors in a model of temporal lobe epilepsy. Epilepsia. 2010;51:415-422.
21. 18F-fallypride. Nucl Med Biol. 1999;26:519-527.
22. 18F]Fallypride dopamine D2 receptor studies using delayed microPET scans and a modified Logan plot. Nucl Med Biol. 2009;36:931-940.
23. 18F-fallypride in nonhuman primates using positron emission tomography. Synapse. 1997; 27:1-13.
24. 18F]-fallypride in monkeys using a PET multiple-injection protocol. J Cereb Blood Flow Metab. 2004;24:309-322.
25. 18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates. Psychopharmacology (Berl). 2004;175:274-286.
26. 18F]fallypride binding in healthy humans. Synapse. 2008;62:399-408.
27. Mukherjee J, Christian BT, Dunigan KA, et al. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors. Synapse. 2002;46:170-188. (Pubitemid 35155170)
28. 3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci. 2009;29:14734-14740.
29. 18F]fluoro-L-dopa studied with PET in normal control and Parkinson's disease subjects. Synapse. 2000;37:81-89.